|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 世界胃肠病学组织(WGO-OMGE)临床指南——发展中国家幽门螺杆菌感染显示文摘我非常高兴向大家推荐这份发展中国家幽门螺杆菌(H.priori)临床指南。该指南的编译是由数位在该领域具有丰富临床经验的世界知名专家共同完成的。 | Hunt RH Xiao SD Megraud F Leon-Barua R Bazzoli F Van der Merwe S vaz Coelho LG Fock KM Fedail S Cohen H Malfertheiner P Vakil N Hamid S Goh KL Wong BC Krabshuis JH 杜颖 丛衍群 戴宁 | 2007 | 胃肠病学2007，12，1： | 85 |
| 2 | 世界胃肠病学组织全球指南——发展中国家幽门螺杆菌感染显示文摘世界上有一半人口感染幽门螺杆菌(H.pylori),其感染率因地理位置、种族、年龄和社会经济状况不同而存在很大差异.在发展中国家较高.发达国家较低。但总体而言,近年世界许多地区的H.pylori感染率均呈下降趋势。 | Hunt RH Xiao SD Megraud F Leon-Barua R Bazzoli F van der Merwe S Vaz Coelho LG Fock M Fedail S Cohen H Malfertheiner P Vakil N Hamid S Goh KL Wong BCY Krabshuis J Le Mair A 杜颖 戴宁 | 2011 | 胃肠病学2011，16，7： | 27 |
| 3 | 抗磷脂综合征诊疗指南显示文摘静脉血栓主要指深静脉血栓形成(deep vein thrombosis,DVT),最常见的部位为腓肠肌静脉,其次为股静脉。深静脉血栓形成相当多见,在美国人群的年发病率为0.1%,每年有超过20万人患DVT,大约10%的DVT患者发生肺栓塞。欧美国家对DVT的诊治与病因研究做了大量的工作,特别是近年来随着临床检验技术与分子生物学的发展,易栓症的各种发病机制已相继发现。约一半的易栓症患者的病因可被确定。 我国尚无DVT的统计资料,一般的印象是低于西方人群,但临床病例日益增多,有的医院已建立了专科病房。总的来讲,我国在心脑血管疾病方面做的工作较多,但对DVT的研究还处于早期阶段,在深度与广度上与国际水平还有较大的距离。另一方面,中国人易栓症发生情况与西方人似有较大的差别。因子VLeiden仅发现两例,凝血酶原G20210A变异尚未见报导。近年来我国血液学会对静脉血栓栓塞的诊断与治疗提出了一系列的指导意见,我们组织翻译了有关资料供有关医务人员参考,以期进一步提高我国DVT的诊断与防治水平,并希望对确定我国DVT诊断与治疗的原则及发展规划有一定的意义。我们将分5个专题介绍这些指导意见,本期介绍的'抗磷脂综合征诊疗指南';'有症状门诊病人深静脉血栓形成的诊断,临床评价和D-二聚体分析可能减少对影像学诊断的需要'。 | Greaves M Cohen H Machin SJ Mackie I 白艳艳 王兆钺 | 2004 | 国外医学(输血及血液学分册)2004，27，5： | 9 |
| 4 | Chronic overexpression of PNPLA3^sup I148M^ in mouse liver causes hepatic steatosis显示文摘 | Li John Zhong Huang Yongcheng Karaman Ruchan Ivanova Pavlina T Brown H Alex Roddy Thomas Castro-Perez Jose Cohen Jonathan C Hobbs Helen H | 2012 | EN2012，，11： | 3 |
| 5 | Fondaparinux预防老年急性内科患者发生静脉血栓形成的效果与安全性:随机安慰剂对照研究显示文摘目的:观察 Fondaparinux 对具有中高度静脉血栓发生危险的老年急性内科住院患者的抗凝效果与安全性。设计:双盲随机安慰剂对照研究。背景:8个国家的35个中心。参与者:849例≥60岁内科患者,住院原因分别为充血性心力衰竭、慢性肺病合并急性呼吸系统疾患、急性炎症性或感染性疾病,预期至少住院4天以上。干预:2.5 mg Fondaparinux 或安慰剂,每天1次皮下注射,持续6~14天。观察指标:主要指标为静脉血栓形成(治疗后15天内采用双侧静脉造影检查)及有症状的静脉血栓;次要指标为死亡与出血。患者随访时间为1个月。结果:Fondaparinux 治疗组425例患者和安慰剂组414例患者接受了安全性分析(10例未治疗)。644例患者(75.9%)可接受主要指标分析。静脉血栓检出率在 Fondaparinux 治疗组为5.6%(18/321),安慰剂组为10.5%(34/323),相对危险减少46.7%(95% CI 7.7%~69.3%)。安慰剂组5例患者发生有症状的静脉血栓,Fondaparinux治疗组无患者发生有症状的静脉血栓(P=0.029)。两组均有1例(0.2%)患者发生严重出血。随访结束时,安慰剂组、Fondaparinux 治疗组分别死亡25(6.0%)、14(3.3%)例患者。结论:Fondaparinux 可有效预防急性内科老年患者无症状性及有症状的静脉血栓。严重出血几率两组相似。 | Alexander T Cohen Bruce L Davidson Alexander S Gallus Michael R Lassen Martin H Prins Witold Tomkowski Alexander G G Turpie Jan F M Egberts Anthonie W A Lensing 石汉平(译) 王深明(校) | 2006 | 英国医学杂志中文版2006，9，5： | 3 |
| 6 | Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source显示文摘BACKGROUND The trans-fat containing AMLN(amylin liver non-alcoholic steatohepatitis,NASH)diet has been extensively validated in C57BL/6J mice with or without the Lep^ob/Lep^ob(ob/ob)mutation in the leptin gene for reliably inducing metabolic and liver histopathological changes recapitulating hallmarks of NASH.Due to a recent ban on trans-fats as food additive,there is a marked need for developing a new diet capable of promoting a compatible level of disease in ob/ob and C57BL/6J mice.AIM To develop a biopsy-confirmed mouse model of NASH based on an obesogenic diet with trans-fat substituted by saturated fat.METHODS Male ob/ob mice were fed AMLN diet or a modified AMLN diet with trans-fat(Primex shortening)substituted by equivalent amounts of palm oil[Gubra amylin NASH,(GAN)diet]for 8,12 and 16 wk.C57BL/6J mice were fed the same diets for 28 wk.AMLN and GAN diets had similar caloric content(40%fat kcal),fructose(22%)and cholesterol(2%)level.RESULTS The GAN diet was more obesogenic compared to the AMLN diet and impaired glucose tolerance.Biopsy-confirmed steatosis,lobular inflammation,hepatocyte ballooning,fibrotic liver lesions and hepatic transcriptome changes were similar in ob/ob mice fed the GAN or AMLN diet.C57BL/6J mice developed a mild to moderate fibrotic NASH phenotype when fed the same diets.CONCLUSION Substitution of Primex with palm oil promotes a similar phenotype of biopsyconfirmed NASH in ob/ob and C57BL/6J mice,making GAN diet-induced obese mouse models suitable for characterizing novel NASH treatments. | Michelle L Boland Denise Oro Kirstine S T■lb■l Sebastian T Thrane Jens Christian Nielsen Taylor S Cohen David E Tabor Fiona Fernandes Andrey Tovchigrechko Sanne S Veidal Paul Warrener Bret R Sellman Jacob Jelsing Michael Feigh Niels Vrang James L Trevaskis Henrik H Hansen | 2019 | World Journal of Gastroenterology2019，25，33： | 3 |
| 7 | Expression transforming growth factor-βeta isoforms in human glomerular disease显示文摘 | YAMAMOTO T NOBLE N A COHEN A H | 1996 | Kidney Int1996，49，2： | 2 |
| 8 | Polar - A potent polyoxin B compound for controlling powdery mildews in apple and nectarine trees, and grapevines 显示文摘 | Reuveni M Cohen H Zahavi T | 2000 | Crop Protect2000，19，6： | 2 |
| 9 | Optimal management of the pancreatic remnant after pancreaticoduodenectomy 显示文摘 | Marcus ST Cohen H Ranson JHC | 1995 | Ann Surg1995，221，： | 2 |
| 10 | Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial显示文摘 | Faramarz Ismail-Beigi Timothy Craven Mary Ann Banerji Jan Basile Jorge Calles Robert M Cohen Robert Cuddihy William C Cushman Saul Genuth Richard H Grimm Bruce P Hamilton Byron Hoogwerf Diane Karl Lois Katz Armand Krikorian Patrick O'Connor Rodica Pop-Bus | 2010 | The Lancet2010，，9739： | 2 |
| 11 | Intention is choice with commitment 显示文摘 | Cohen P R Levesque H J | 1990 | Artificial Intelligence1990，42，： | 1 |
| 12 | Drug exposure and psoriasis vulgaris: Case-control and case-crossover studies 显示文摘 | Cohen AD Bonneh DY Reuveni H | 2005 | Acta Derm Venereol2005，85，4： | 1 |
| 13 | FDA drug approval summary: erlotinib (tarveva) tablets显示文摘 | COHEN M H JOHNSON J R CHEN Y F | 2005 | Oncologist2005，10，7： | 1 |
| 14 | Perforin and lymphohistioeytosis proliferative disorders 显示文摘 | Katono H Cohen JI | 2005 | Br J Haemetol2005，128，6： | 1 |
| 15 | Serum uric acid and cardiovascular evetlts in successfully treated htpertensive patients 显示文摘 | Alderman MH Cohen H Madhavan S | 1999 | Hypertension1999，34，1： | 1 |
| 16 | Effect of transcranial magnetic stimulation in posttraumatic stress disorder:a preliminary study显示文摘 | Grisaru N Amir M Cohen H | 1998 | Biol Psychiatry1998，，44： | 1 |
| 17 | Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats显示文摘 | Cohen H Zohar J Gidron Y | 2006 | Biol Psychiatry2006，59，： | 1 |
| 18 | Criteria in the choice of an occluding cuff for the indirect measurement of blood pressure显示文摘 | Alexander H Cohen ML Steinfeld L | 1977 | Med Biol Eng Comput1977，15，： | 1 |
| 19 | Polarization rotation mechanism for ultrahigh electromechanical response in single-crystal piezoelec- trics 显示文摘 | FU H COHEN R E | 2000 | Nature2000，403，： | 1 |
| 20 | Residents' Attitudes Towards an Instant Resort Enclave显示文摘 | Hemandez S A J Cohen H L Garcia | 1996 | Annals of Tourism Research1996，23，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员